Find and Pitch Jounalists, Get Your Story Covered

Tags: TechnipFMC Petrobras iEPCI Department Stores department-stores

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	MindMed begins phase 3 study of MM120 for anxiety disorder - 5 days ago Bayer begins inhibitor study treating advanced KRAS-mutated tumours - 10 days ago Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - 12 days ago Osivax begins phase 2a booster trial for influenza vaccine - about 1 month ago Microbiotica begins human trials for ulcerative colitis treatment - about 1 month ago Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug - about 2 months ago Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease - 3 months ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 7 months ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Fixed-Duration Acalabrutinib and Venetoclax Regimens Redefine First-Line Treatment Options for Patients With CLL - 13 days ago Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Is New Standard of Care for High-Risk Early-Stage TNBC - 3 months ago FDA Breakthrough Therapy Designation Granted to Novel Psychedelic Molecule CYB003 for Major Depressive Disorder - 9 months ago Phase 3 Study Supports Pembrolizumab Plus Lenvatinib as Standard of Care in Patients With Advanced Endometrial Cancer Who Received Prior Platinum Therapy - about 1 year ago
3	Michael DePeau-Wilson MedPage Today Enterprise Reporter. AI in Healthcare focus. Journalism alum. Not specified healthcareartificial intelligencejournalismpodcasting	Novel PTSD Treatment Improved Symptom Severity in Phase IIb Trial - 13 days ago
4	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped? - 3 months ago
5	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 3 months ago STAT+: Viking Therapeutics to move its oral obesity drug into Phase 2 study after early success - 9 months ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis - 3 months ago FDA Grants Orphan Drug, Fast Track Designation to RLS-0071 for aGVHD - 4 months ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - 4 months ago AstraZeneca to Initiate Trial for Triple-Combination Inhaled Therapy for Chronic Obstructive Pulmonary Disease - 9 months ago Samsung Bioepis Initiates Phase 1 Trial for Proposed Keytruda Biosimilar - 10 months ago FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma - about 1 year ago AB-1002 Demonstrates Improvements for Congestive Heart Failure in First-in-Human Study - about 1 year ago Phase 3 Trials of Survodutide for Overweight, Obesity to Begin Recruiting Patients - about 1 year ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GSK5764227 Receives Breakthrough Therapy Designation to Treat Extensive-Stage Small–Cell Lung Cancer - 4 months ago FDA Grants Priority Review for Durvalumab to Treat Small Cell Lung Cancer - 4 months ago FDA Grants Fast Track Designation for LYT-200 to Treat Head and Neck Cancers - 8 months ago FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer - 8 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 9 months ago Phase 3 Trial of Pembrolizumab with Olaparib Did Not Meet Endpoints Among Individuals with NSCLC - 9 months ago Phase 3 EVOKE-01 Study in Metastatic NSCLC Falls Short of Primary Endpoint - 10 months ago Researchers Announce Positive Trial Data for the Use of Remibrutinib In Chronic Spontaneous Urticaria - about 1 year ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - 4 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 9 months ago
9	Kristen Monaco MedPage Today	Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 5 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - about 1 year ago
10	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Novel TKI Promising in Early Study of HER2-Mutant NSCLC - 6 months ago

Journalists covering Phase 1b/2 Trial